CClinicalTrials.gg
Not yet recruitingNCT06990282Updated May 25, 2025

Micro-Needling Technique Using Ozonated Olive Oil in Periodontal Diseases

A Phase 2 interventional study of microneedling and scaling in Periodontal Diseases, Periodontitis and Treatment Need and Gingivitis, sponsored by Fayoum University. Not yet recruiting at 1 site in Egypt. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-05-25.

Sponsored by Fayoum University · Phase 2, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Feb 2026, 8 months ago, but the record still lists the study as not yet recruiting.
Phase
Phase 2
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The research idea is based on using micro-acupuncture therapy with ozone-treated olive oil to improve the condition of patients suffering from gingivitis and periodontitis and comparing it to the scientifically proven conventional treatment. This is a randomized controlled study, and this idea was chosen from the current general trend in medicine, particularly in dentistry, to use natural sources for treatment due to fewer side effects compared to the chemicals used.

Read the detailed description

The research idea is based on the use of microneedling treatment with ozone-treated olive oil to improve the condition of patients suffering from gingivitis and periodontitis, and to compare this with scientifically proven traditional treatment. It is a randomized controlled study, and this idea has been selected from the general trend currently prevalent in the field of medicine in general and dentistry in particular, which utilizes natural sources for treatment due to the reduced side effects compared to chemical substances used. Research objectives and rationale: to find simple, proven solutions accessible to everyone that rely on natural sources to treat one of the widely spread oral diseases, which negatively affects the patient's overall health and dental health, potentially leading to tooth loss and deteriorating the patient's oral and psychological health as well. The proposed solutions will be compared with scientifically proven solutions that are used regularly to treat this disease. Expected results: that the new intervention using ozone-treated natural olive oil with the microneedling device, which has shown significant effectiveness in various specialties such as dermatology and dentistry, will improve the healing process of the gum membranes And the removal of the inflammations causing deterioration of the membranes surrounding the teeth and the bone resorption around them, which may lead to tooth loss, should improve better than the conventional methods currently used. This involves using laboratory analyses to observe the improvement rates of biological indicators by taking a sample of the gingival crevicular fluid before starting the intervention and afterward, with regular patient follow-up until clinical signs improve. Multiple readings should be taken to assess the improvement in the quality of the membranes, ensuring that the new intervention is simple and accessible to everyone. Operational background: This research is based on numerous previous studies from references, case reports, and analytical studies in the same field published in international scientific journals. Their effectiveness and credibility have been proven by specialists through published systematic reviews, along with the opinions of specialized consultants.

02

Conditions studied

  • Periodontal Diseases
  • Periodontitis and Treatment Need
  • Gingivitis
03

In context

Gingivitis

590 studies on the registry are indexed under Gingivitis; 105 are open to participants now.

This study's planned enrollment of 30 is below the median of 64 across 478 interventional studies indexed under Gingivitis.

Browse Gingivitis studies →

Lead sponsor

Fayoum University is the lead sponsor of 144 studies on the registry; 41 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 18-60 years old
  • Male and female medically free participants
  • Patients suffering from biofilm induced gingivitis or periodontitis

Exclusion criteria

Exclusion Criteria:

  • Smoking and tobacco related habits
  • Non-biofilm induced gingival diseases
  • Necrotizing periodontal diseases
  • periodontitis as a manifestation of systemic disease
  • Third molar tooth
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    biofilm induced gingivitis treated with microneedling & topical ozonated olive oil.

    biofilm induced gingivitis treated with microneedling \& topical ozonated olive oil

    Other: microneedling · Other: scaling · Biological: Ozonated olive oil

  • Experimental
    Periodontitis cases treated by scaling only.

    Periodontitis cases treated by (PMPR) only.

    Other: scaling

  • Experimental
    Periodontitis cases treated with microneedling and topical ozonated olive oil.

    Periodontitis cases treated with microneedle (Dermapen) and topical ozonated olive oil.

    Other: microneedling · Other: scaling · Biological: Ozonated olive oil

Interventions

  • Othermicroneedling

    gingival microneedling (small holes in gingiva)

  • Otherscaling

    scaling (plaque removal)

  • BiologicalOzonated olive oil

    ozonated olive oil after microneedling

06

What researchers measure

Primary outcomes

  1. bleeding on probing

    Muehlemann \& Son index

    Time frame: 4 weeks

  2. Plaque index

    Silness-Loe Plaque Index

    Time frame: 4 weeks

  3. probing depth and clinical attachment loss

    measured in mm using a UNC 15 probe

    Time frame: 4 weeks

Secondary outcomes

  1. malondialdehyde and 8-hydroxy-deoxyguanosin level in GCF.

    measured by ELISA

    Time frame: 4 weeks

07

Study locations

1 site
  • Fayoum University
    Fayoum, Egypt
08

References and documents

Individual participant data

Plan to share: Yes — upon request

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06990282
Lead sponsor
Fayoum University
Responsible party
Heba Mohammed Hussien Ali (teaching assistant, Fayoum University) — Principal investigator
First posted
May 25, 2025
Start date
Jul 1, 2025 (estimated)
Primary completion
Feb 2026 (estimated)
Completion
Mar 2026 (estimated)
Last update
May 25, 2025

Study contacts

heba Alnjar
Contact
hmh14@fayoum.edu.eg
+201023717086
Nayroz Tarrad, Prof
study director · Fayoum University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion